Anshu Malik
Overview
Explore the profile of Anshu Malik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Komuro H, Kawai-Harada Y, Aminova S, Pascual N, Malik A, Contag C, et al.
Nanotheranostics
. 2023 Jan;
7(1):90.
PMID: 36593798
[This corrects the article DOI: 10.7150/ntno.54879.].
2.
Sivaraj S, Copeland J, Malik A, Pasini E, Angeli M, Azhie A, et al.
Clin Transplant
. 2021 Nov;
36(2):e14534.
PMID: 34781411
Long-term survival after Liver Transplantation (LT) is often compromised by infectious and metabolic complications. We aimed to delineate alterations in intestinal microbiome (IM) over time that could contribute to medical...
3.
Komuro H, Kawai-Harada Y, Aminova S, Pascual N, Malik A, Contag C, et al.
Nanotheranostics
. 2021 Apr;
5(4):378-390.
PMID: 33912378
Extracellular vesicles (EVs) are naturally released, cell-derived vesicles that mediate intracellular communication, in part, by transferring genetic information and, thus, have the potential to be modified for use as a...
4.
Gogoi H, Mani R, Malik A, Sehrawat P, Bhatnagar R
Vaccines (Basel)
. 2020 Oct;
8(4).
PMID: 33019545
Aluminium salts have been the adjuvant of choice in more than 100 licensed vaccines. Here, we have studied the synergistic effect of aluminium hydroxide nanoparticles (AH np) and non-ionic surfactant-based...
5.
Gogoi H, Mani R, Aggarwal S, Malik A, Munde M, Bhatnagar R
Int J Nanomedicine
. 2020 Feb;
15:239-252.
PMID: 32021177
Introduction: Aluminum salts, although they have been used as adjuvants in many vaccine formulations since 1926, exclusively induce a Th2-biased immune response, thereby limiting their use against intracellular pathogens like...
6.
Joshi H, Malik A, Aggarwal S, Munde M, Maitra S, Adlakha N, et al.
Int J Nanomedicine
. 2020 Jan;
14:10023-10033.
PMID: 31908457
Purpose: The objective of this research was to generate a tool for the first-line detection of fungal infection in plants. Chitin is one of the unique fungal cell wall polysaccharide...
7.
Malik A, Gupta M, Mani R, Bhatnagar R
Int J Nanomedicine
. 2019 May;
14:3129-3143.
PMID: 31118627
Background: Bacillus Calmette-Guérin, the attenuated strain of , remains the only available vaccine against tuberculosis (TB). However, its ineffectiveness in adults against pulmonary TB and varied protective efficacy (0-80%) speak...
8.
Malik A, Gupta M, Gupta V, Gogoi H, Bhatnagar R
Int J Nanomedicine
. 2018 Dec;
13:7959-7970.
PMID: 30538470
The application of natural carbohydrate polysaccharides for antigen delivery and its adjuvanation potential has garnered interest in the scientific community in the recent years. These biomaterials are considered favorable candidates...
9.
Mani R, Gupta M, Malik A, Tandon R, Prasad R, Bhatnagar R, et al.
Infect Immun
. 2018 Aug;
86(10).
PMID: 30104212
Novel adjuvants are in demand for improving the efficacy of human vaccines. The immunomodulatory properties of cell wall components have been highlighted in the formulation of complete Freund's adjuvant (CFA)....
10.
Malik A, Gupta M, Mani R, Gogoi H, Bhatnagar R
Front Immunol
. 2018 Apr;
9:562.
PMID: 29616046
Anthrax is an era old deadly disease against which there are only two currently available licensed vaccines named anthrax vaccine adsorbed and precipitated (AVP). Though they can provide a protective...